Dwight Reynolds to Cardiac Pacing, Artificial
This is a "connection" page, showing publications Dwight Reynolds has written about Cardiac Pacing, Artificial.
Connection Strength
2.804
-
Impact of operator experience and training strategy on procedural outcomes with leadless pacing: Insights from the Micra Transcatheter Pacing Study. Pacing Clin Electrophysiol. 2017 Jul; 40(7):834-842.
Score: 0.546
-
Apparent acute reversible right ventricular pacing-induced left ventricular dysfunction. J Cardiovasc Electrophysiol. 2013 Feb; 24(2):224-6.
Score: 0.396
-
New concepts in physiologic cardiac pacing. Curr Cardiol Rep. 2007 Sep; 9(5):351-7.
Score: 0.277
-
Leadless intracardiac pacemakers: MACE, including death, in context. Heart Rhythm. 2021 07; 18(7):1140-1141.
Score: 0.177
-
Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing. Europace. 2019 Nov 01; 21(11):1686-1693.
Score: 0.161
-
Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019 04; 30(4):569-574.
Score: 0.153
-
Health-related quality of life impact of a transcatheter pacing system. J Cardiovasc Electrophysiol. 2018 12; 29(12):1697-1704.
Score: 0.150
-
Physical activity detection in patients with intracardiac leadless pacemaker. J Cardiovasc Electrophysiol. 2018 12; 29(12):1690-1696.
Score: 0.149
-
Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017 05; 14(5):702-709.
Score: 0.133
-
Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial. Heart Rhythm. 2017 05; 14(5):685-691.
Score: 0.133
-
Rate adaptive pacing in an intracardiac pacemaker. Heart Rhythm. 2017 02; 14(2):200-205.
Score: 0.131
-
The rationale and design of the Micra Transcatheter Pacing Study: safety and efficacy of a novel miniaturized pacemaker. Europace. 2015 May; 17(5):807-13.
Score: 0.117
-
Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009 Dec; 158(6):956-64.
Score: 0.081
-
Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana. Heart Rhythm. 2005 Sep; 2(9):1025-33.
Score: 0.060
-
Interventions in the diagnosis and adoption of pacemaker therapy in sinus node dysfunction patients: Results from the IMPROVE Brady study. Indian Heart J. 2022 Sep-Oct; 74(5):351-356.
Score: 0.049
-
The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol. 2002 Feb; 25(2):260-4.
Score: 0.047
-
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010 Sep; 3(5):596-605.
Score: 0.021
-
Addendum to the clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm. 2005 Oct; 2(10):1161-3.
Score: 0.015
-
Cross-talk in bipolar pacemakers. Pacing Clin Electrophysiol. 1989 Oct; 12(10):1613-21.
Score: 0.005
-
Direct endocardial recording from an accessory atrioventricular pathway: localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation. Circulation. 1983 Nov; 68(5):906-16.
Score: 0.003